Fleury Michon Acquires UK Plant-Based Food Company All Plants
Bitget2026/10/20 17:06- Fleury Michon completed its acquisition of 100% of British plant-based food business All Plants today.
- All Plants generates about EUR 5 million in annual revenue, less than 1% of group sales, with EBITDA near break-even.
- The acquisition provides a platform to expand the group's plant-based range in the UK, a more developed market than France.
- The deal includes all commercial operations, employees and rights to the All Plants brand.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
